Rainbow Children’s Hospital reports 23% revenue growth in Q2 FY27

Rainbow Children’s Medicare Limited has announced its financial results for the second quarter of Fiscal Year 2027 (Q2 FY27), ending September 30, 2026. The company reported a substantial 23% year-over-year increase in revenue, reaching ₹5,480 million. EBITDA also saw a significant rise of 14% to ₹1,700 million, demonstrating robust financial performance and operational efficiency across its hospital network.

Rainbow Children’s Hospital Reports Strong Q2 FY27 Performance

Rainbow Children’s Medicare Limited has released its financial results for the second quarter of Fiscal Year 2027 (Q2 FY27), a period concluding on September 30, 2026. The company showcased impressive growth, with revenue from operations climbing by 23.2% year-over-year to ₹5,480.2 million. This significant increase reflects the company’s expanding market presence and operational capabilities.

Key Financial Highlights

In addition to revenue growth, the total income for the quarter also saw a healthy increase of 22.8%, reaching ₹5,561.5 million. The company’s operational efficiency is further highlighted by its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) figures. EBITDA (Post Ind AS 116) stood at ₹1,699.8 million, marking a 14.2% increase over the corresponding period in the previous year. Profit After Tax (PAT) also demonstrated positive momentum, increasing by 10.9% to ₹838.9 million.

Half-Yearly Performance

Looking at the first half of FY27 (H1 FY27), Rainbow Children’s Medicare Limited continued its growth trajectory. Revenue from operations for H1 FY27 grew by 27.6% to ₹10,180.1 million. Total income for the half-year period rose by 25.8% to ₹10,388.4 million. EBITDA (Post Ind AS 116) for H1 FY27 was ₹3,046.3 million, a 20.6% increase year-over-year. PAT for the half-year period increased by 13.1% to ₹1,464.3 million.

Operational Metrics

The presentation also detailed operational key performance indicators. For Q2 FY27, the company noted increases in IP Discharges (+15%) and OP Consultations (+19%). The number of Deliveries saw a significant jump of +20%. Occupancy rates remained strong, and Average Revenue Per Occupied Bed (ARPOB) saw a notable 10% increase. The Average Length of Stay (ALOS) remained stable with a marginal -3% change.

Source: BSE

Previous Article

Studds Accessories board approves Q2 financial results and grants stock options

Next Article

Neogen Chemicals approves material related party transactions up to ₹500 crore